Mir-149-3p and method for treating metabolic disease using the same
AssigneeHenan University
InventorsWeidong CHEN, Xiaobo NIE, Yandong WANG, Yun ZHOU, Xinrui LV
Life of this patent
Estimating the term…
Loading patent…
AssigneeHenan University
InventorsWeidong CHEN, Xiaobo NIE, Yandong WANG, Yun ZHOU, Xinrui LV
Estimating the term…
MicroRNA, including one of or a combination of the following components: (a) a pri-miRNA of miR-149-3p; (b) a pre-miRNA of miR-149-3p; (c) a mature miRNA of miR-149-3p; (d) a miR-149-3p derivative; (e) a 18-26 nucleotides miRNA having a sequence of 5′-AGGGAGG-3′; and (f) a derivative of the 18-26 nucleotides miRNA of (e). Also provided is a method for treating a metabolic disease. The method includes employing a DNA sequence encoding miR-149-3p as a target gene, constructing an overexpression vector of the miR-149-3p, preparing a pharmaceutical composition including the overexpression vector of the miR-149-3p, and administering the pharmaceutical composition to a patient in need thereof.
MicroRNA, comprising one of or a combination of the following:
A method for treating a metabolic disease, the method comprising employing a DNA sequence encoding miR-149-3p as a target gene, constructing an overexpression vector of the miR-149-3p, preparing a pharmaceutical composition comprising the overexpression vector of the miR-149-3p, and administering the pharmaceutical composition to a patient in need thereof.
Dependencies are inferred from the claim text.